Le Lézard
Classified in: Health
Subject: MRR

Global Continuous Glucose Monitoring (CGM) Solutions Markets Report 2023-2027: Opportunities in Type 2 Diabetic and Non Diabetic Patients Treatment Boost Future Growth Potential

DUBLIN, June 8, 2023 /PRNewswire/ -- The "Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

Technological advancements and strategic partnerships create new opportunities for CGM vendors.

The rising prevalence of diabetes entails a greater need for treatment and monitoring. In this context, multiple growth opportunities arise in the continuous glucose monitoring (CGM) solutions market. CGM devices have been extensively used for Type 1 diabetes patients. With further technological development and clinical studies, CGM's applications expand toward Type 2 diabetes, prediabetes, weight management, nutrition tracking, and metabolic health tracking.

Most Type 1 diabetes patients - the main users of CGM - do not use these solutions due to their high costs and low reimbursements, especially in low and middle-income countries. The adoption of these devices is very low in Asia-Pacific, Latin America, the Middle East, and Africa due to low accessibility, awareness, and affordability. A vast patient pool of diabetic and prediabetic patients needing treatment in these regions creates attractive opportunities for CGM vendors.

Vendors in the CMG solutions industry are partnering with various players across the diabetes treatment ecosystem to increase CGM adoption, data integration, and device combability. Examples of these partnerships are common between CGM vendors and insulin pens, insulin pumps, and diabetes management platform providers. 

Research Highlights

Key Topics Covered:

1. Strategic Imperatives

2. Growth Opportunity Analysis

3. Regional and Country Opportunities Analysis

4. Total Addressable Market for CGM

5. New Business Models and Technologies

6. Growth Opportunity Analysis - Homecare Settings

7. Growth Opportunity Analysis - Hospitals and Other Care Settings

8. Growth Opportunity Universe

For more information about this report visit https://www.researchandmarkets.com/r/p4m86t

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

These press releases may also interest you

at 17:45
The "Magnetic Stirrer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global magnetic stirrer market has been on a steady growth trajectory,...

at 17:15
Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare genetic diseases, today announced the approval of Evkeeza® (evinacumab) in Canada. Evkeeza® was...

at 17:15
The Electrophysiology Catheters Market size is expected to grow by USD 2.24 billion, accelerating at a CAGR of 8.73% during the forecast period, according to Technavio Research. Companies are implementing various strategies like forming partnerships,...

at 17:15
The "Probiotic Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global probiotic ingredients market has been on an upward...

at 17:01
The relapsed/refractory multiple myeloma market landscape is undergoing a radical transformation with the recent FDA approvals of two CAR-Ts which is opening up new avenues for companies developing later lines of therapy. Several key players are...

at 17:00
Precision Optics Corporation, Inc. (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call to discuss fourth quarter and...

News published on and distributed by: